LRP5 and breast cancer: Here, we show that conditioned medium from LRP5-overexpressing MLO-A5 osteocytes markedly inhibits EO771 breast cancer cell proliferation, migration, and invasion, and alters the expression of key tumor-related proteins—effects that are mediated by upregulation of LIMA1.